Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In Untreated MDS, AML and CMML Patients (BRIGHT 1012) |
---|---|
Disease/Condition | Myelodysplastic Syndrome (MDS),Hematologic Diseases,Oncology (Medical/Hematologic),Leukemia,Neoplasms |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Amit Verma, MD |
Contact Name | Apoorva Talanki |
Contact Email | atalanki@montefiore.org |
IRB/Protocol Number | 14-06-415-01 |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Higher Risk Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), or Chronic Myelomonocytic Leukemia (CMML) |